Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Efficacy and safety of a chinese herbal formula (invigorating kidney and strengthening spleen) in chronic hepatitis B virus carrier: results from a multicenter, randomized, double-blind, and placebo-controlled trial.

He J, Zhou D, Tong G, Xing Y, Chen Y, Zhang X, Zhan B, Gao H, Zhou X, Xiong Y, Liu X, Peng L, Qiu M, Zheng Y.

Evid Based Complement Alternat Med. 2013;2013:961926. doi: 10.1155/2013/961926. Epub 2013 Jul 10.

2.

[Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].

Ling N, Zhou Z, Zhang DZ, Ren H.

Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):346-9. Chinese.

PMID:
17524266
3.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

5.

A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.

Yao GB, Cui ZY, Wang BE, Yao JL, Zeng MD.

Hepatobiliary Pancreat Dis Int. 2004 May;3(2):188-93.

6.
7.

[Long-term effect of lamivudine treatment in chronic hepatitis B virus infection].

Yao G, Wang B, Cui Z.

Zhonghua Gan Zang Bing Za Zhi. 1999 Jun;7(2):80-3. Chinese.

PMID:
10488413
8.

[The long-term efficacy of lamivudine in chronic hepatitis B: interim analysis of 3-year's clinical course].

Yao GB, Wang BE, Cui ZY, Yao JL, Zeng MD.

Zhonghua Nei Ke Za Zhi. 2003 Jun;42(6):382-7. Chinese.

PMID:
12895320
9.

An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.

Yao G, Cui Z, Wang B, Yao J, Zeng M.

Chin Med J (Engl). 2002 Dec;115(12):1814-8.

PMID:
12622930
10.

Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Zhu XJ, Sun XH, Zhou ZH, Liu SQ, Lv H, Li M, Li L, Gao YQ.

Evid Based Complement Alternat Med. 2013;2013:620230. doi: 10.1155/2013/620230. Epub 2013 Aug 24.

11.

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J.

Hepatology. 2008 Feb;47(2):447-54.

PMID:
18080339
12.

A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B.

Zeng M, Mao Y, Yao G, Wang H, Hou J, Wang Y, Ji BN, Chang CN, Barker KF.

Hepatology. 2006 Jul;44(1):108-16.

PMID:
16799983
13.

[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial].

Lu LG, Zeng MD, Mao YM, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X, Ye J, Zhou XQ, Wang H, Wu SM, Tang MF, Zhu JS, Chen WX.

Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):597-600. Chinese.

PMID:
15504289
14.

[Efficacy of adefovir dipivoxil was not related to genotypes B and C of hepatitis B virus: a randomized, double-blind, multicenter clinical study].

Zhao H, Li J, Zhang YX, Chen XY, Wang L, Tang XP, Lei CL, Si CW.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007 Sep;21(3):282-4. Chinese.

PMID:
17971947
15.

[A clinical study of adefovir dipivoxil in treating lamivudine refractory HBeAg-positive chronic hepatitis B].

Zhao H, Zhang YX, Chen XY, Wang L, Tang XP, Si CW.

Zhonghua Nei Ke Za Zhi. 2007 Apr;46(4):294-7. Chinese.

PMID:
17637268
16.

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

Lai CL, Ching CK, Tung AK, Li E, Young J, Hill A, Wong BC, Dent J, Wu PC.

Hepatology. 1997 Jan;25(1):241-4.

PMID:
8985298
17.

[Analysis of a randomized, double-blind, double-dummy, controlled, multicenter study confirmed the similar therapeutic efficacies of entecavir maleate and entecavir for treatment of HBeAg-positive chronic hepatitis B].

Xu JH, Yu YY, Si CW, Zeng Z, Li J, Mao Q, Zhang DZ, Tang H, Sheng JF, Chen XY, Ning Q, Shi GF, Xie Q, Zhang XQ, Dai J, Xu ZN.

Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):881-5. doi: 10.3760/cma.j.issn.1007-3418.2013.12.001. Chinese.

PMID:
24636286
18.

[Clinical investigation of famciclovir in chronic hepatitis B patients irresponsive to alpha interferon treatment].

Wang ZY, Guo SH, Zhang DF, Zhao YR, Ren H, Zhou XQ, Xu DZ, Sun JY, Yao JL, Lu WL.

Zhonghua Gan Zang Bing Za Zhi. 2005 Jul;13(7):494-6. Chinese.

PMID:
16042882
19.

A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.

Piccolo P, Lenci I, Demelia L, Bandiera F, Piras MR, Antonucci G, Nosotti L, Mari T, De Santis A, Ponti ML, Sorbello O, Iacomi F, Angelico M.

Antivir Ther. 2009;14(8):1165-74. doi: 10.3851/IMP1466.

PMID:
20032546
20.

Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.

Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F.

Am J Gastroenterol. 2005 Apr;100(4):856-61.

PMID:
15784032

Supplemental Content

Support Center